European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Next PostHMOs offer protection from tooth decay as formula ingredient You Might Also Like Type 3 resistant starch from Canna edulis modulates obesity and low grade inflammation in mice November 24, 2021 Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation February 6, 2019 International Research on Dietary Fiber September 2, 2017
Type 3 resistant starch from Canna edulis modulates obesity and low grade inflammation in mice November 24, 2021
Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation February 6, 2019